Eurointervention

Papers
(The median citation count of Eurointervention is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
TAVR under 70: is age just a number?225
International variation in modality and outcomes of left main revascularisation: does it really matter?119
Double-tap to treat paravalvular leak in high-risk annuli99
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity86
In search of the origin of the acronym TAVI75
Transcatheter left ventriculoplasty74
Transapical transcatheter mitral valve implantation in patients with prior aortic valve replacement: a feasibility report74
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis66
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s58
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis57
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study54
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry50
Recanalisation of coronary chronic total occlusions49
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement47
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure46
Defer-based non-stenting: a promising approach for STEMI45
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarc43
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve42
Hybrid coronary revascularisation: the best or the worst of both worlds?41
Thermodilution-derived temperature recovery time: a novel predictor of microvascular reperfusion and prognosis after myocardial infarction41
The “road travelled”: reflections on the transformation of information exchange in a digital age40
   Atrial fibrillation and acute coronary syndrome 40
One-month DAPT after acute coronary syndrome: too short or not too short?38
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study37
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document36
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation36
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection35
Redo transcatheter mitral valve replacement in mitral annular calcification35
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial32
Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis32
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes31
Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons30
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD29
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study28
Comparison of acute thrombogenicity and albumin adsorption in three different durable polymer coronary drug-eluting stents28
Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial28
A novel robotic radiation shielding device for interventional cardiology procedures28
Chordal replacement and annuloplasty in one transfemoral device for degenerative mitral regurgitation27
A novel three-dimensional imaging approach to evaluate coronary access before transcatheter aortic valve-in-valve implantation27
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement27
Antithrombotic therapy for transcatheter structural heart intervention26
Oesophageal and gastric injuries caused by transoesophageal probe manipulation in patients undergoing transcatheter edge-to-edge repair for tricuspid regurgitation26
Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry25
Device entrapment during percutaneous coronary intervention of chronic total occlusions: incidence and management strategies25
Cerebral embolic protection during transcatheter heart interventions25
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the ra25
Percutaneous versus surgical transaxillary access for transcatheter aortic valve replacement: a propensity-matched analysis of the US experience25
A nationwide analysis of reperfusion therapies for pulmonary embolism in older patients with frailty24
Management of cardiogenic shock24
Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study24
Early outcomes of transcatheter mitral valve replacement with the Tendyne system in severe mitral annular calcification23
Coronary lithotripsy for the treatment of underexpanded stents: the international multicentre CRUNCH registry23
ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation22
Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial21
SYNTAXES, biomarkers and survival in complex coronary artery disease: the intervention of secondary prevention21
Shifting focus in bifurcations.21
Optical coherence tomography to visualise the endothelialisation of left atrial appendage occluders21
TAVI patients with bystander coronary artery disease should receive PCI: pros and cons20
Prevention of left ventricular outflow tract obstruction in transapical mitral valve replacement: the MitraCut procedure20
Determinants of adverse outcomes following patent foramen ovale closure in elderly patients19
Acute and one-year clinical outcomes of pre-stenting intravascular ultrasound: a patient-level meta-analysis of randomised clinical trials19
New-onset atrial fibrillation detected by ambulatory ECG monitoring after transcatheter aortic valve implantation19
UNICA − a novel single-stent, double-valve, heterotopic, cross-caval approach for severe tricuspid insufficiency 19
Procedural and early outcomes of transcatheter edge-to-edge mitral valve repair in very elderly patients19
Is transcatheter aortic valve implantation safe in patients with left ventricular outflow tract calcification?19
Coronary CT as a first-line investigation in chronic coronary syndromes: pros and cons18
The ongoing conundrum of the best care for patients presenting with non-ST-segment elevation acute coronary syndrome18
Near-infrared spectroscopy to predict plaque progression in plaque-free artery regions17
Safety of absolute coronary flow and microvascular resistance measurements by thermodilution17
The patent foramen ovale does not spontaneously close in patients aged 6017
Robotics, imaging, and artificial intelligence in the catheterisation laboratory17
Supporting evidence for ST-segment elevation myocardial infarction from optical coherence tomography17
Ticagrelor-based antiplatelet therapy after percutaneous coronary intervention in chronic coronary syndrome17
Predictors and clinical impact of worsening left ventricular ejection fraction after mitral transcatheter edge-to-edge repair16
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation16
Targeting inflammation in atherosclerosis: overview, strategy and directions16
Three-year outcomes of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic stenosis16
Diagnostic accuracy of quantitative flow ratio in patients with arrhythmias16
Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis16
Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?16
Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?15
SAPIEN 3 Ultra: better sealing, reduced paravalvular leak and a move in the right direction?15
Left atrial appendage closure for thrombus trapping: the international, multicentre TRAPEUR registry15
Anterior mitral leaflet modification with endoscopic scissors during Tendyne implantation15
Stent underexpansion in the CRUNCH registry: worth cracking?15
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI15
Direct oral anticoagulants for ventricular thrombus resolution: pilot trials show reassuring efficacy and safety compared to warfarin15
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis14
Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair14
Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI Registry14
PCR London Valves - in person or online - an invaluable opportunity for exchange dedicated to advancing the treatment of valvular heart disease14
EuroIntervention: the 200th issue14
Letter: Caffeine and fractional flow reserve overestimation: a word of caution14
We now have enough evidence to support systematic OCT in daily PCI practice: pros and cons13
Severely calcified coronary stenoses: a war or a battle?13
Reply: Spontaneous coronary artery dissection in France13
Vessel fractional flow reserve (vFFR) for the assessment of stenosis severity: the FAST II study13
Combined functional and anatomical assessment of coronary stenosis by coronary CT angiography13
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trials12
Transcatheter aortic valve implantation in degenerated surgical aortic valves12
Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies11
Device-related thrombus following left atrial appendage occlusion11
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interv11
Changes in absolute coronary flow and microvascular resistance during exercise in patients with ANOCA11
Skating on thin ice: searching for vulnerable plaques11
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial11
Transcatheter closure of atrial septal defect and patent foramen ovale with Carag bioresorbable septal occluder: first-in-man experience with 24-month follow-up10
Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation10
A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study10
Transcatheter interventions for heart failure10
Percutaneous Valvular and Structural Heart Disease Interventions.2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with 10
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary 10
One-step anatomic and function testing by cardiac CT versus second-line functional testing in symptomatic patients with coronary artery stenosis: head-to-head comparison of CT-derived fractional flow 10
Completeness of revascularisation in acute coronary syndrome patients with multivessel disease10
Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: a statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)10
Incidence and clinical impact of major bleeding following left atrial appendage occlusion: insights from the Amplatzer Amulet Observational Post-Market Study10
My stroke story9
Paravalvular regurgitation after transcatheter aortic valve replacement in intermediate-risk patients: a pooled PARTNER 2 study9
Coronary sinus reducer therapy for refractory angina: is it ready for prime time?9
Coronary access after transcatheter aortic valve replacement in bicuspid versus tricuspid aortic stenosis9
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study9
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial8
Impact of mitral regurgitation aetiology on the outcomes of transcatheter aortic valve implantation8
Changes in post-PCI optimisation strategies with post-procedural FFR followed by IVUS8
Controlled antegrade and retrograde subintimal tracking (CART) for recanalisation of chronic total occlusions8
Commissural alignment with the novel Hydra transcatheter heart valve during aortic valve replacement8
Temporal patterns, characteristics, and predictors of clinical outcomes in patients undergoing percutaneous coronary intervention for stent thrombosis8
First experience of left atrial appendage occlusion using a 3D mini transoesophageal echocardiographic probe with conscious sedation8
Understanding the past, getting prepared for the future. (Going from in vivo to in vitro to in silico)8
Letter: When is the optimal time point for detecting malapposition in coronary bifurcation trials?7
Timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome: long-term clinical outcomes from the nationwide SWEDEHEART registry7
Coronary artery cannulation after transcatheter aortic valve implantation7
Pulmonary artery denervation – the suspense continues?7
Timing of bioprosthetic valve fracture in transcatheter valve-in-valve intervention: impact on valve durability and leaflet integrity7
Thirty years of transradial coronary interventions7
“Lotus root”: a novel optical coherence tomography imaging pattern in spontaneous coronary artery dissection7
Repeat transcatheter aortic valve implantation and implications for transcatheter heart valve performance: insights from bench testing7
A deep learning algorithm for detecting acute myocardial infarction7
Breaking down the barriers in the management of INOCA: how can we do better in the diagnosis of coronary vasomotor disorders?6
Impact of moderate or severe left ventricular outflow tract calcification on clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation with self- and6
Robotic-assisted percutaneous coronary intervention: the future or the past?6
Safety and efficiency of percutaneous coronary intervention using a standardised optical coherence tomography workflow6
Outcomes by sex in the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial6
Echocardiographic guidance in transcatheter structural cardiac interventions6
Transcatheter tricuspid interventions are performed too late: pros and cons6
Outcomes of directional atherectomy for common femoral artery disease6
Super high-pressure balloon versus scoring balloon to prepare severely calcified coronary lesions: the ISAR-CALC randomised trial6
Microaxial flow pump for high-risk PCI: are we ready for the prime time?5
Treatment of coronary bifurcation lesions, part II: implanting two stents. The 16th expert consensus document of the European Bifurcation Club5
New-onset or newly detected atrial fibrillation after transcatheter aortic valve implantation?5
Durability of transcatheter aortic valve implantation in bicuspid aortic valve stenosis: the last missing piece?5
Radial wall strain: a novel angiographic measure of plaque composition and vulnerability5
Transseptal puncture: procedural guidance, challenging situations and management of complications5
Histological examination of renal nerve distribution, density, and function in humans5
TAVI at 20: how a crazy idea led to a clinical revolution5
Rotational atherectomy combined with cutting balloon to optimise stent expansion in calcified lesions: the ROTA-CUT randomised trial5
ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike5
The 17th expert consensus document of the European Bifurcation Club – techniques to preserve access to the side branch during stepwise provisional stenting4
Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trial4
Scores and algorithms in CTO PCI: “PROGRESS” or an exercise in futility?4
Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation4
Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SOR4
Outcomes of quantitative flow ratio-based percutaneous coronary intervention in an all-comers study4
TAVI in asymptomatic patients with severe aortic stenosis: pros and cons4
Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial4
Electrosurgical laceration and stabilisation of three clip devices (ELASTA-Clip) to enable transcatheter mitral valve implantation4
Embolisation of a prosthetic mitral valve fragment during valve-in-valve transcatheter mitral valve implantation4
Reply: The time has come to use attitudinally appropriate terminology when describing cardiac anatomy4
Proximal optimisation technique versus final kissing balloon inflation in coronary bifurcation lesions: the randomised, multicentre PROPOT trial4
Routine cerebral embolic protection in transcatheter aortic valve implantation: rationale and design of the randomised British Heart Foundation PROTECT-TAVI trial4
Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a multicentre registry4
Low-flow, low-gradient aortic stenosis: an understanding is still a long way off4
Treatment of patent foramen ovale4
Consider aspirin bridging for non-cardiac surgery in patients with coronary stents treated with oral anticoagulation monotherapy4
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial4
Low urine pH: a new marker for contrast-associated acute kidney injury?4
Prevalence, predictors, and outcomes of in-stent restenosis with calcified nodules3
Cost-effectiveness of an FFR-guided strategy during STEMI – no rose without a thorn3
A comparison of risk prediction models for patients with acute coronary syndromes3
Letter: Composite endpoints in clinical trials - simplicity or perfection?3
A prospective, first-in-human use of the NeVa mechanical thrombectomy device for patients with acute coronary syndromes3
Clinical outcomes of the ACURATE neo2 transcatheter heart valve: a prospective, multicentre, observational, post-market surveillance study3
Transcatheter aortic valve implantation of a novel system for severe pure native aortic regurgitation in a patient with an ascending aorta aneurysm3
Quantitative flow ratio versus fractional flow reserve for Heart Team decision-making in multivessel disease: the randomised, multicentre DECISION QFR trial3
Prognostic impact and clinical outcomes of coronary flow reserve and hyperaemic microvascular resistance3
Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial3
VA-ECMO in cardiogenic shock: is the road closed or open?3
Treatment of severe aortic valve regurgitation with the Trilogy TAVI system3
Stop at the yellow light spot: in vivo detection of preclinical atherosclerosis3
Transcatheter tricuspid valve repair/replacement should be offered to all patients with severe tricuspid regurgitation: pros and cons3
Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO)3
Feasibility of redo-TAVI in the self-expanding ACURATE neo2 valve: a computed tomography study2
Letter: ORBITA-2 trial design and rationale: what causes angina after PCI?2
Reply: ORBITA-2 trial design and rationale: what causes angina after PCI?2
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial2
A bench study of balloon-expandable valves for the treatment of self-expanding valve failure2
TAVI in moderate aortic stenosis and heart failure: pros and cons2
Catheter directed therapies: an option for elderly frail patients with pulmonary embolism requiring reperfusion2
First-in-human description of a novel transcatheter tricuspid valve prosthesis to preserve the asymmetric shape of the right ventricle2
Mechanical thrombectomy for pulmonary embolism revisited: technological breakthrough or simple renovation?2
In search of the “IDEAL” left main coronary stent and DAPT regimen2
Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month D2
Intravascular ultrasound guidance for lower extremity arterial and venous interventions2
PCI of bystander coronary artery lesions should be performed before TAVI: pros and cons2
Temporal trends in clinical outcomes after percutaneous coronary intervention: a systematic review of 66,327 patients from 25 all-comers trials2
Transcatheter edge-to-edge mitral valve repair in patients with mitral annulus calcification2
Valve-in-valve TAVI: the new standard therapy for failing bioprosthetic valves?2
Economic evaluation of fractional flow reserve-guided versus angiography-guided multivessel revascularisation in ST-segment elevation myocardial infarction patients in the FLOWER-MI randomised trial2
Prevalence and patterns of in-stent neoatherosclerosis in lower extremity artery disease2
Letter: Pretreatment with unfractioned heparin in patients undergoing primary PCI: a standard of treatment together with DAPT?2
Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged2
Comprehensive diagnosis in chronic coronary syndromes combining angiography and intracoronary testing: the AID-ANGIO study2
Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trial2
Standardisation of techniques for bifurcation stenting optimisation: the journey continues2
Transcatheter edge-to-edge repair of severe calcific mitral regurgitation facilitated by balloon lithotripsy2
Long-term outcomes of catheter-based intervention for clinically significant paravalvular leak2
A study of the novel SinoCrown system for transcatheter aortic valve implantation2
Women and coronary artery disease: not just underrepresented and underdiagnosed, but also undertreated!2
Phasic flow patterns of right versus left coronary arteries in patients undergoing clinical physiological assessment2
Balloon-expandable versus self-expanding stents in native coarctation of the aorta: three-year results of a randomised controlled trial 2
0.069068193435669